CIK 0001070081 · Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043416587
- Phone
- 9082227000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,752,145
- in 10 filings, $7.8M under 10b5-1 plans
Net −$7,752,145. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-24 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise 10b5-1 | +6,101 | $33.02 | $201K | 106,726 |
| 2025-11-24 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −6,101 | $80.17 | $489K | 100,625 |
| 2025-11-24 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,900 | 15,600 | ||
| 2025-11-24 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,650 | 70,850 | ||
| 2025-11-24 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,715 | 10,885 | ||
| 2025-11-24 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −21,206 | 49,644 | ||
| 2025-11-24 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,101 | 11,399 | ||
| 2025-11-21 | Reeve Emma Director | Option exercise 10b5-1 | +10,000 | $51.16 | $512K | 16,666 |
| 2025-11-21 | Reeve Emma Director | Sale 10b5-1 | −10,000 | $79.50 | $795K | 6,666 |
| 2025-11-21 | Reeve Emma Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 0 | ||
| 2025-11-20 | Okey Stephanie Director | Gift | −867 | 8,000 | ||
| 2025-11-17 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +2,812 | $25.69 | $72K | 106,713 |
| 2025-11-17 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −1,843 | $75.64 | $139K | 104,870 |
| 2025-11-17 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −777 | $76.53 | $59K | 104,093 |
| 2025-11-17 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −192 | $77.18 | $15K | 103,901 |
| 2025-11-17 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,812 | 25,314 | ||
| 2025-11-12 | Reeve Emma Director | Option exercise 10b5-1 | +7,333 | $46.54 | $341K | 13,999 |
| 2025-11-12 | Reeve Emma Director | Sale 10b5-1 | −7,333 | $74.50 | $546K | 6,666 |
| 2025-11-12 | Reeve Emma Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,333 | 1,467 | ||
| 2025-10-30 | Reeve Emma Director | Sale 10b5-1 | −3,666 | $69.50 | $255K | 6,666 |
Page 19 of 25 · 493 trades